Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012;7(1):e30856.
doi: 10.1371/journal.pone.0030856. Epub 2012 Jan 23.

Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial

Affiliations
Randomized Controlled Trial

Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial

Chuan Zhang et al. PLoS One. 2012.

Abstract

Objective: To explore the best interventions and working patterns of clinical pharmacists in pediatrics and to determine the effectiveness of clinical pharmacists in pediatrics.

Methods: We conducted a randomized controlled trial of 160 pediatric patients with nerve system disease, respiratory system disease or digestive system disease, who were randomly allocated into two groups, with 80 in each group. Interventions by clinical pharmacists in the experimental group included answering questions of physicians and nurses, giving advice on treating patients, checking prescriptions and patient counseling at discharge. In the control group, patients were treated without clinical pharmacist interventions.

Results: Of the 109 interventions provided by clinical pharmacists during 4 months, 47 were consultations for physicians and nurses, 31 were suggestions of treatment, with 30 accepted by physicians (96.77%) and 31 were medical errors found in 641 prescriptions. Five adverse drug reactions were submitted to the adverse drug reaction monitoring network, with three in the experimental group and two in the control group. The average length of stay (LOS) for patients with respiratory system diseases in the experimental group was 6.45 days, in comparison with 10.83 days in the control group, which was statistically different (p value<0.05); Average drug compliance rate in the experimental group was 81.41%, in comparison with 70.17% of the control group, which was statistically different (p value<0.05). Cost of drugs and hospitalization and rate of readmission in two weeks after discharge in the two groups were not statistically different.

Conclusion: Participation by clinical pharmacists in the pharmacotherapy of pediatric patients can reduce LOS of patients with respiratory system disease and improve compliance rate through discharge education, showing no significant effects on prevention of ADR, reduction of cost of drugs and hospitalization and readmission rate in two weeks.

Trial registration: Chinese Clinical Trial Registry ChiCTR-TRC-10001081.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Trial flow chart.

References

    1. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, et al. Survey of unlicensed and off label drug use in pediatric wards in European countries. BMJ. 2000;320:79–82. - PMC - PubMed
    1. Promoting safety of medicines for children [EB/OL]. www.who.com 2010-1-20.
    1. Wong ICK, Ghaleb MA, Franklin-Dean B, Barber N. Incidence and nature of dosing errors in pediatric medications. Drug Safety. 2004;27:661–70. - PubMed
    1. Academic Health Centers. Leading Change in the 21st Century. Washington, DC: National Academy Press; 2003.
    1. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human. Washington, DC: National Academy Press; 2000. - PubMed

Publication types

MeSH terms